PFM
Privium Fund Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.18M | Buy |
253,304
+3,500
| +1% | +$127K | 1.98% | 12 |
|
|
2025
Q1 | $9.05M | Sell |
249,804
-8,576
| -3% | -$311K | 2.36% | 7 |
|
|
2024
Q4 | $10.9M | Buy |
258,380
+15,868
| +7% | +$668K | 2.46% | 10 |
|
|
2024
Q3 | $13.5M | Sell |
242,512
-9,090
| -4% | -$505K | 3.35% | 8 |
|
|
2024
Q2 | $10.3M | Buy |
251,602
+36,500
| +17% | +$1.5M | 2.63% | 10 |
|
|
2024
Q1 | $10M | Buy |
215,102
+48,596
| +29% | +$2.27M | 2.68% | 10 |
|
|
2023
Q4 | $8.02M | Buy |
166,506
+51,265
| +44% | +$2.47M | 2.23% | 13 |
|
|
2023
Q3 | $4.11M | Buy |
115,241
+3,000
| +3% | +$107K | 1.22% | 25 |
|
|
2023
Q2 | $5.24M | Buy |
112,241
+1,500
| +1% | +$70K | 1.51% | 20 |
|
|
2023
Q1 | $4.44M | Buy |
110,741
+4,000
| +4% | +$160K | 1.49% | 22 |
|
|
2022
Q4 | $4.82M | Buy |
106,741
+24,400
| +30% | +$1.1M | 1.83% | 19 |
|
|
2022
Q3 | $3.34M | Sell |
82,341
-22,558
| -22% | -$915K | 1.21% | 28 |
|
|
2022
Q2 | $6.26M | Sell |
104,899
-7,828
| -7% | -$467K | 2.07% | 15 |
|
|
2022
Q1 | $8.19M | Buy |
112,727
+10,896
| +11% | +$791K | 1.81% | 15 |
|
|
2021
Q4 | $8.58M | Buy |
+101,831
| New | +$8.58M | 1.7% | 19 |
|